Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

por Schnackenberg, Christine G., Costell, Melissa H., Krosky, Daniel J., Cui, Jianqi, Wu, Charlene W., Hong, Victor S., Harpel, Mark R., Willette, Robert N., Yue, Tian-Li
Publicado 2013